BR8008053A - Processo e sistema para a reducao de populacao ativa de linfocitos em suprimento de sangue e sistema para tratamento de sangue de um paciente - Google Patents

Processo e sistema para a reducao de populacao ativa de linfocitos em suprimento de sangue e sistema para tratamento de sangue de um paciente

Info

Publication number
BR8008053A
BR8008053A BR8008053A BR8008053A BR8008053A BR 8008053 A BR8008053 A BR 8008053A BR 8008053 A BR8008053 A BR 8008053A BR 8008053 A BR8008053 A BR 8008053A BR 8008053 A BR8008053 A BR 8008053A
Authority
BR
Brazil
Prior art keywords
blood
subject
lymphocytes
reducing
psoralen
Prior art date
Application number
BR8008053A
Other languages
English (en)
Inventor
R Edelson
Original Assignee
Leukocyte Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leukocyte Res Inc filed Critical Leukocyte Res Inc
Publication of BR8008053A publication Critical patent/BR8008053A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3616—Batch-type treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A61M1/3686—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents by removing photoactive agents after irradiation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00—Surgery
    • Y10S128/03—Heart-lung

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Radiation-Therapy Devices (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR8008053A 1979-12-11 1980-12-10 Processo e sistema para a reducao de populacao ativa de linfocitos em suprimento de sangue e sistema para tratamento de sangue de um paciente BR8008053A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/102,553 US4321919A (en) 1979-12-11 1979-12-11 Method and system for externally treating human blood

Publications (1)

Publication Number Publication Date
BR8008053A true BR8008053A (pt) 1981-06-23

Family

ID=22290431

Family Applications (1)

Application Number Title Priority Date Filing Date
BR8008053A BR8008053A (pt) 1979-12-11 1980-12-10 Processo e sistema para a reducao de populacao ativa de linfocitos em suprimento de sangue e sistema para tratamento de sangue de um paciente

Country Status (13)

Country Link
US (1) US4321919A (pt)
EP (1) EP0030358B1 (pt)
JP (1) JPS5930683B2 (pt)
AT (1) ATE12352T1 (pt)
AU (1) AU546122B2 (pt)
BR (1) BR8008053A (pt)
CA (1) CA1153334A (pt)
DE (1) DE3070398D1 (pt)
DK (1) DK520080A (pt)
ES (1) ES497578A0 (pt)
IL (1) IL61658A0 (pt)
NO (1) NO803706L (pt)
ZA (1) ZA807529B (pt)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4398906A (en) * 1979-12-11 1983-08-16 Frederic A. Bourke, Jr. Method for externally treating the blood
US4612007A (en) * 1981-06-16 1986-09-16 Edelson Richard Leslie Method and system for externally treating the blood
US4684521A (en) * 1982-12-08 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4613322A (en) * 1982-12-08 1986-09-23 Edelson Richard Leslie Method and system for externally treating the blood
US4683889A (en) * 1983-03-29 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US5176921A (en) * 1983-05-02 1993-01-05 Diamond Scientific Co. Method of blood component decontamination by glucose addition
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
EP0124363B1 (en) * 1983-05-02 1990-12-19 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4946438A (en) * 1983-09-01 1990-08-07 The Trustees Of Columbia University In The City Of New York Process for development of acceptance of transplanted organs and tissues
WO1985000954A1 (en) * 1983-09-01 1985-03-14 The Trustees Of Columbia University In The City Of Processes for development of acceptance of transplanted organs and tissues
US4861704A (en) * 1983-09-01 1989-08-29 The Trustees Of Columbia University In The City Of New York Processes for development of acceptance of transplanted organs and tissues
CA1253115A (en) * 1983-09-29 1989-04-25 Extracorporeal Medical Specialties, Inc. Apparatus and methods for treating cells with radiation
US4568328A (en) * 1984-10-29 1986-02-04 Extracorporeal Medical Specialties, Inc. Automated photophoresis blood portion control methods and apparatus
US4573960A (en) * 1984-10-29 1986-03-04 Extracorporeal Medical Specialties, Inc. Three phase irradiation treatment process
US4708715A (en) * 1984-10-29 1987-11-24 Mcneilab, Inc. Light array assembly for photoactivation patient treatment system
US4681568A (en) 1984-10-29 1987-07-21 Mcneilab, Inc. Valve apparatus for photoactivation patient treatment system
US4608255A (en) * 1985-01-31 1986-08-26 American National Red Cross Biocompatible method for in situ production of functional platelets and product produced thereby lacking immunogenicity
JPS61153487U (pt) * 1985-03-12 1986-09-22
US4998931A (en) * 1985-07-05 1991-03-12 Puget Sound Blood Center Method of reducing immunogenicity and inducing immunologic tolerance
US5039483A (en) * 1987-03-10 1991-08-13 The Medical College Of Wisconsin, Inc. Antiprotozoan method
US4915683A (en) * 1986-11-21 1990-04-10 The Medical College Of Wisconsin, Inc. Antiviral method, agents and apparatus
US4775625A (en) * 1986-11-21 1988-10-04 The Medical College Of Wisconsin, Inc. Inactivating enveloped viruses with a merocyanine dye
US5304113A (en) * 1986-11-21 1994-04-19 The Mcw Research Foundation, Inc. Method of eradicating infectious biological contaminants
US4838852A (en) * 1987-03-27 1989-06-13 Therakos, Inc. Active specific immune suppression
US4960408A (en) * 1989-01-10 1990-10-02 Klainer Albert S Treatment methods and vaccines for stimulating an immunological response against retroviruses
US5284869A (en) * 1991-12-17 1994-02-08 Emil Bisaccia Photophoresis methods for treating atherosclerosis and for preventing restenosis following angioplasty
IL92996A (en) * 1989-01-10 1996-06-18 Bisaccia Emil Photovoltaic compounds as drugs for the treatment of viral infections and a method for the production of vaccines
US4921473A (en) * 1989-02-02 1990-05-01 Therakos, Inc. Multicomponent fluid separation and irradiation system
US4999375A (en) * 1989-04-11 1991-03-12 Hoffmann-La Roche Inc. Psoralen reagent compositions for extracorporeal treatment of blood
US5503721A (en) 1991-07-18 1996-04-02 Hri Research, Inc. Method for photoactivation
DE4005704A1 (de) * 1990-02-23 1991-08-29 Amelung Doris Verfahren zur blutbehandlung durch sauerstoff und licht und vorrichtung zur durchfuehrung dieses verfahrens
US5418130A (en) * 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
EP0516839B1 (en) * 1990-12-20 1999-11-24 Baxter International Inc. Systems and methods for simultaneously removing free and entrained contaminants in fluids like blood using photoactive therapy and cellular separation techniques
ZA919934B (en) * 1990-12-20 1992-09-30 Baxter Int Systems and methods for eradicating contaminants using photoactive materials in fluids like blood using discrete sources of radiation
JP3051996B2 (ja) * 1990-12-20 2000-06-12 バクスター、インターナショナル、インコーポレイテッド 液体中の汚染物を根絶するためのシステム
EP0516836B1 (en) * 1990-12-20 1996-03-13 Baxter International Inc. A device and method for eradicating contaminants in fluids
US5116864A (en) * 1991-04-09 1992-05-26 Indiana University Foundation Method for preventing restenosis following reconfiguration of body vessels
US5263925A (en) * 1991-07-22 1993-11-23 Gilmore Jr Thomas F Photopheresis blood treatment
US5219882A (en) * 1991-10-24 1993-06-15 Emil Bisaccia Treatment methods for lymes disease and associated debilitating conditions
US5288605A (en) * 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US6433343B1 (en) 1992-03-02 2002-08-13 Cerus Corporation Device and method for photoactivation
ES2147203T3 (es) * 1992-08-07 2000-09-01 Cerus Corp Procedimientos de inactivacion de bacterias en las preparaciones a base de sangre con la ayuda de 8-metoxipsoraleno.
US5651993A (en) 1992-11-18 1997-07-29 Yale University Specific immune system modulation
DE4317600C2 (de) * 1993-05-27 1995-07-13 Ulrich Heinrich C Kompressionsapparat zur Herstellung einer künstlichen Blutleere an Extremitäten
US6420570B1 (en) 1993-06-28 2002-07-16 Cerus Corporation Psoralen compounds
US5625079A (en) 1993-06-28 1997-04-29 Cerus Corporation Synthesizing psoralen compounds useful as intermediates
US5399719A (en) 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
US5527704A (en) 1994-12-06 1996-06-18 Baxter International Inc. Apparatus and method for inactivating viral contaminants in body fluids
US5669396A (en) * 1996-01-16 1997-09-23 President And Fellows Of Harvard College Methods of detecting and treating vaso-occlusive crisis in sickle cell disease
ATE307634T1 (de) * 1996-03-29 2005-11-15 Therakos Inc Photopherese-behandlung von hcv-infektionen
WO1997036581A1 (en) * 1996-03-29 1997-10-09 Therakos, Inc. Photopheresis treatment of leukocytes
EP0892599A4 (en) 1996-04-09 2001-05-16 Therakos Inc PROCESS FOR THE ELIMINATION OF PSORALENES IN BIOLOGICAL FLUIDS
JP4180116B2 (ja) 1996-11-22 2008-11-12 セラコス・インコーポレイテッド 攬拌を取り入れた血液製剤照射装置
US5951509A (en) * 1996-11-22 1999-09-14 Therakos, Inc. Blood product irradiation device incorporating agitation
CA2295572C (en) * 1997-07-10 2010-07-06 Therakos, Inc. Treatment of inflammatory disorders of the bowel and urinary bladder
ES2210846T3 (es) * 1997-11-20 2004-07-01 Cerus Corporation Nuevos psoralenos para inactivar agentes patogenos.
US7049110B2 (en) * 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US20070099170A1 (en) * 1998-07-21 2007-05-03 Navigant Biotechnologies, Inc. Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate
US20030215784A1 (en) * 1998-07-21 2003-11-20 Dumont Larry Joe Method and apparatus for inactivation of biological contaminants using photosensitizers
US7498156B2 (en) * 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US6113566A (en) * 1998-12-15 2000-09-05 Foundation For Blood Irradiation Inc. Ultraviolet blood irradiation method and apparatus
US7109031B2 (en) * 1999-04-20 2006-09-19 Yale University Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
US20050158856A1 (en) * 1999-04-20 2005-07-21 Edelson Richard L. Methods for producing functional antigen presenting dendritic cells using biodegradable microparticles for delivery of antigenic materials
US20050084966A1 (en) * 1999-04-20 2005-04-21 Edelson Richard L. Methods for inducing the differentiation of blood monocytes into functional dendritic cells
EP1176986B1 (en) 1999-04-20 2018-07-04 Yale University Differentiation of monocytes into functional dendritic cells
US6219584B1 (en) 1999-07-09 2001-04-17 Therakos, Inc. Method and system for determining an effective amount of light energy to delivery to fluids having targets for the light energy
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US6495366B1 (en) * 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
US8722422B2 (en) 1999-09-03 2014-05-13 Therakos, Inc. Uninterrupted flow pump apparatus and method
US6719715B2 (en) * 1999-09-16 2004-04-13 Vasogen Ireland Limited Apparatus and process for conditioning organic fluid
PT1267931E (pt) * 1999-10-05 2005-05-31 Hopital Maisonneuve Rosemont Derivados de rodamina para o diagnostico e tratamento fotodinamicos
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
US6793643B1 (en) 2000-04-21 2004-09-21 Therakos, Inc. Low extracorporeal volume treatment system
TW590780B (en) * 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7985588B2 (en) * 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US7648699B2 (en) * 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
US6843961B2 (en) * 2000-06-15 2005-01-18 Gambro, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
CN1289150C (zh) * 2000-11-13 2006-12-13 拜尔公司 使用紫外线辐射对流体中的微生物进行灭活的方法
EP1990055A3 (en) * 2001-11-29 2011-11-16 Therakos, Inc. Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
US7186230B2 (en) 2002-03-04 2007-03-06 Therakos, Inc Method and apparatus for the continuous separation of biological fluids into components
US7211037B2 (en) * 2002-03-04 2007-05-01 Therakos, Inc. Apparatus for the continuous separation of biological fluids into components and method of using same
US7479123B2 (en) 2002-03-04 2009-01-20 Therakos, Inc. Method for collecting a desired blood component and performing a photopheresis treatment
US20040127840A1 (en) 2002-03-04 2004-07-01 Steve Gara Blood separation apparatus and method of using the same
EP1496947A1 (en) * 2002-04-24 2005-01-19 Gambro, Inc. Removal of adenine during a process of pathogen reducing blood and blood components
US20050080373A1 (en) * 2003-10-09 2005-04-14 Xiaoling Wang Apparatus and a method for treating blood related illnesses
AU2004237844B2 (en) 2003-12-23 2011-01-27 Therakos, Inc. Extracorporeal photopheresis in combination with anti-TNF treatment
US7087177B2 (en) * 2004-04-16 2006-08-08 Baxter International Inc. Methods for determining flow rates of biological fluids
NZ544247A (en) * 2004-12-22 2007-06-29 Omj Ireland Ltd Phototherapy using psoralen derivatives and a UVB absorber
ES2633102T3 (es) * 2005-11-02 2017-09-19 Therakos, Inc. El uso de células apoptóticas ex vivo para generar linfocitos T reguladores
EP2527840A3 (en) 2006-05-02 2013-01-09 Therakos, Inc. Methods and reagents for detecting susceptilbility to graft versus host disease
ITVE20070005A1 (it) * 2007-01-25 2008-07-26 Associazione Veneta Per La Lotta Alla Talassemia Farmaco per la cura della talassemia, dell'anemia falciforme e di tutte le altre forme di anemia trattabili con questo, metodo di attivazione del farmaco, composizione farmaceutica avente come principio attivo il farmaco e metodo fotochemioterapico u
JP2010519955A (ja) * 2007-03-01 2010-06-10 ナノスペクトラ、バイオサイアンセズ、インク 循環する細胞の体外アブレーションのためのデバイスおよび方法
WO2009018309A2 (en) * 2007-08-01 2009-02-05 Caridianbct Biotechnologies, Llc Pathogen inactivation of whole blood
WO2009026073A1 (en) * 2007-08-22 2009-02-26 Caridianbct Biotechnologies, Llc Prevention of transfusion related acute lung injury using riboflavin and light
US9458498B2 (en) * 2011-01-24 2016-10-04 Takara Bio Inc. Method for modifying nucleic acids
US9399093B2 (en) * 2012-01-27 2016-07-26 Fenwal, Inc. Systems and methods for performing online extracorporeal photopheresis
US11678825B2 (en) 2018-10-04 2023-06-20 Fenwal, Inc. Methods and systems for collecting samples in a photopheresis procedure
US11883543B2 (en) 2019-04-16 2024-01-30 Fenwal, Inc. Systems and methods for photoactivation of a biological fluid
KR102252218B1 (ko) 2019-11-01 2021-05-14 김진왕 친환경 스마트 혈액 모듈레이션 장치

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1683877A (en) * 1927-03-03 1928-09-11 Lester A Edblom Means for treating blood-stream infections
FR975851A (fr) * 1948-12-04 1951-03-12 Appareil d'irradiation par rayons ultra-violets du sang d'un malade
US3325641A (en) * 1964-02-17 1967-06-13 George W Jones Apparatus for treating a thin film of liquid by exposure to radiant energy
US3788319A (en) * 1971-07-30 1974-01-29 Univ Iowa State Res Found Inc System for exchanging blood ultrafiltrate
FR2426473A1 (fr) * 1978-05-26 1979-12-21 Carraz Gilbert Procede et dispositif de traitement de la leucemie par circulation extra-corporelle du sang

Also Published As

Publication number Publication date
JPS56131520A (en) 1981-10-15
EP0030358A2 (en) 1981-06-17
ATE12352T1 (de) 1985-04-15
CA1153334A (en) 1983-09-06
DE3070398D1 (en) 1985-05-02
NO803706L (no) 1981-06-12
EP0030358B1 (en) 1985-03-27
ZA807529B (en) 1981-07-29
ES8202484A1 (es) 1982-02-01
AU6517180A (en) 1981-06-18
JPS5930683B2 (ja) 1984-07-28
IL61658A0 (en) 1981-01-30
AU546122B2 (en) 1985-08-15
US4321919A (en) 1982-03-30
EP0030358A3 (en) 1982-03-24
ES497578A0 (es) 1982-02-01
DK520080A (da) 1981-06-12

Similar Documents

Publication Publication Date Title
BR8008053A (pt) Processo e sistema para a reducao de populacao ativa de linfocitos em suprimento de sangue e sistema para tratamento de sangue de um paciente
US5628727A (en) Extracorporeal virioncidal apparatus
US4398906A (en) Method for externally treating the blood
US4464166A (en) Method for externally treating the blood
DE68922456D1 (de) Krebsbehandlung.
DE69733826D1 (de) Behandlung von leukocyten durch photopheresis
EP0180452A3 (en) Three-phase irradiation blood-treatment process
DE68915834D1 (de) Herstellung von T-Zellen und T-Zellmembranen, verwendbar zur Verhütung und Behandlung von Autoimmunkrankheiten.
ES8400669A1 (es) "un metodo de reducir la poblacion en accion de un constituyente de sangre en el suministro de sangre de un individuo humano e instalacion correspondiente".
ES2042667T3 (es) Procedimiento para la fabricacion de un preparado de transferina, biologicamente activo, seguro contra virus, de gran pureza.
FR2426473A1 (fr) Procede et dispositif de traitement de la leucemie par circulation extra-corporelle du sang
Zheng et al. The activating action of low level helium neon laser radiation on macrophages in the mouse model
JPH0847528A (ja) 人の血液中に存在する細菌又はウイルス等を失活又は低減させる装置
RU2152788C1 (ru) Способ экстракорпоральной иммунокоррекции у детей с гнойно-септическими заболеваниями
DE10017148A1 (de) Inaktivierung von Viren im Blut
RU1818101C (ru) Способ детоксикации организма при отравлени х снотворными и психотропными средствами
JPS63200769A (ja) 体外循環回路
RU2228531C2 (ru) Способ терапевтического воздействия на организм
RU2093216C1 (ru) Способ обработки крови
RU2034550C1 (ru) Способ п.н.орлова получения средства для лечения гнойных ран
Patrice et al. Parameters Influencing Photodynamic Selectivity of Normal Progenitors vs Leukemia Cells
JPH05132424A (ja) 赤血球を含む血液製剤の紫外線照射方法
Gunn et al. 5133932 Blood processing apparatus
Schoendorfer 5135667 Method and apparatus for administration of anticoagulant to red cell suspension output of a blood separator
RU95118732A (ru) Способ лечения острых радиационных поражений

Legal Events

Date Code Title Description
MK Patent expired

Effective date: 19951210

B15K Others concerning applications: alteration of classification

Ipc: A61M 1/36 (2006.01)